|
Market Closed -
Sao Paulo
15:39:51 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 83.72 BRL | +15.11% |
|
+25.10% | +18.07% |
| 10-30 | US Equity Markets End Lower After Sell-Off in Technology Stocks | MT |
| 10-30 | Regeneron Pharmaceuticals, Inc. announces Quarterly dividend, payable on December 03, 2026 | CI |
| Market Cap | 93.11B 506B 83.39B 76.71B 69.5B 130B 8,841B 132B 915B 367B 4,651B 349B 342B 14,666B | P/E 2026 * |
14.4x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 85.69B 465B 76.74B 70.59B 63.96B 120B 8,136B 122B 842B 338B 4,280B 322B 315B 13,497B | EV / Sales 2026 * |
4.87x | EV / Sales 2027 * | 4.17x |
| Free-Float |
71.06% | Yield 2026 * |
0.43% | Yield 2027 * | 0.46% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +15.11% | ||
| 1 week | +25.10% | ||
| 1 month | +27.91% | ||
| 3 months | +30.26% | ||
| 6 months | +43.73% | ||
| Current year | +18.07% |
| 1 week | 71.76 | 84.06 | |
| 1 month | 60.22 | 84.06 | |
| Current year | 50 | 84.06 | |
| 1 year | 50 | 84.06 | |
| 3 years | 44.82 | 111.72 | |
| 5 years | 44.82 | 111.72 | |
| 10 years | 18.16 | 111.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
George Sing
BRD | Director/Board Member | 76 | 1988-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +15.11% | +25.10% | - | - | 92.65B | ||
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | ||
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | ||
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | ||
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | ||
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | ||
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | ||
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | ||
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | ||
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | ||
| Average | +3.39% | +5.90% | +46.58% | +84.56% | 473.55B | |
| Weighted average by Cap. | +2.29% | +6.60% | +50.51% | +100.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.6B 95.59B 15.77B 14.5B 13.14B 24.56B 1,672B 25.02B 173B 69.43B 879B 66.07B 64.66B 2,773B | 19.59B 106B 17.54B 16.14B 14.62B 27.33B 1,860B 27.84B 192B 77.25B 978B 73.51B 71.95B 3,085B |
| Net income | 6.88B 37.34B 6.16B 5.67B 5.13B 9.6B 653B 9.78B 67.56B 27.12B 343B 25.81B 25.26B 1,083B | 6.12B 33.22B 5.48B 5.04B 4.57B 8.54B 581B 8.69B 60.1B 24.12B 306B 22.96B 22.47B 964B |
| Net Debt | -7.42B -40.31B -6.65B -6.12B -5.54B -10.36B -705B -10.55B -72.93B -29.28B -371B -27.86B -27.27B -1,169B | -11.48B -62.33B -10.28B -9.46B -8.57B -16.02B -1,090B -16.32B -113B -45.27B -573B -43.08B -42.16B -1,808B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | R$83.72 | +15.11% | 856 |
| 26-10-28 | R$72.73 | +0.68% | 215 |
| 26-10-27 | R$72.24 | -0.48% | 734 |
| 26-10-26 | R$72.59 | +8.47% | 3,596 |
| 26-10-23 | R$66.92 | -3.24% | 8,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
Select your edition
All financial news and data tailored to specific country editions

















